ATE242001T1 - Pulverförmiges arzneimittel enthaltend interzelluläres adhäsionsmolekül - Google Patents

Pulverförmiges arzneimittel enthaltend interzelluläres adhäsionsmolekül

Info

Publication number
ATE242001T1
ATE242001T1 AT97907981T AT97907981T ATE242001T1 AT E242001 T1 ATE242001 T1 AT E242001T1 AT 97907981 T AT97907981 T AT 97907981T AT 97907981 T AT97907981 T AT 97907981T AT E242001 T1 ATE242001 T1 AT E242001T1
Authority
AT
Austria
Prior art keywords
sicam
product containing
adhesion molecule
medicinal product
intercellular adhesion
Prior art date
Application number
AT97907981T
Other languages
English (en)
Inventor
Eugene J Mcnally
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21757501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE242001(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of ATE242001T1 publication Critical patent/ATE242001T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97907981T 1996-03-06 1997-03-04 Pulverförmiges arzneimittel enthaltend interzelluläres adhäsionsmolekül ATE242001T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1294496P 1996-03-06 1996-03-06
PCT/US1997/003263 WO1997032596A1 (en) 1996-03-06 1997-03-04 Intercellular adhesion molecule powder formulation

Publications (1)

Publication Number Publication Date
ATE242001T1 true ATE242001T1 (de) 2003-06-15

Family

ID=21757501

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97907981T ATE242001T1 (de) 1996-03-06 1997-03-04 Pulverförmiges arzneimittel enthaltend interzelluläres adhäsionsmolekül

Country Status (8)

Country Link
US (1) US6365343B1 (de)
EP (1) EP0885010B1 (de)
JP (1) JP2000507221A (de)
AT (1) ATE242001T1 (de)
CA (1) CA2244894A1 (de)
DE (1) DE69722594T2 (de)
DK (1) DK0885010T3 (de)
WO (1) WO1997032596A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2518102C (en) * 2003-03-04 2009-05-12 Tanabe Seiyaku Co., Ltd. Powdery preparation for nasal administration
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
GB2420707A (en) * 2004-10-11 2006-06-07 Nasaleze Patents Ltd Compositions for intranasal administration
WO2009040020A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Amylin as a therapeutic agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2141076T3 (es) * 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
CA2008368C (en) * 1989-01-24 2003-04-08 Jeffrey Greve Soluble molecule related to but distinct from icam-1
US5235049A (en) * 1989-01-24 1993-08-10 Molecular Therapeutics, Inc. Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
EP0391088B1 (de) * 1989-03-16 1997-01-02 Center For Blood Research, Inc. Verwendung von funkionellen Derivaten des Interzellulär-Adhäsions-Moleküls ICAM-1 in einer Antivirus-Therapie
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
GB9414966D0 (en) * 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents
US5879712A (en) 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced

Also Published As

Publication number Publication date
US6365343B1 (en) 2002-04-02
WO1997032596A1 (en) 1997-09-12
DE69722594D1 (de) 2003-07-10
DE69722594T2 (de) 2004-04-29
CA2244894A1 (en) 1997-09-12
EP0885010A1 (de) 1998-12-23
DK0885010T3 (da) 2003-09-15
EP0885010B1 (de) 2003-06-04
JP2000507221A (ja) 2000-06-13

Similar Documents

Publication Publication Date Title
MD1813B2 (en) Purified cyclodextrin derivatives of sulphoalkyl ethers or mixtures thereof, clathrate complex of cyclodextrin derivatives with medicamental content and pharmaceutical composition
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
AU9062998A (en) Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
SE9700135D0 (sv) New formulation
YU49279B (sh) Postupak za pripremanje farmaceutske formulacije za dobijanje leka za inhalacionu primenu
NO984376L (no) Mikrosfµrer av polysakkarid for administrering av medikamenter til lungene
PL337794A1 (en) Pharmaceutic agent for oral administration containing an active substance and cyclodextrin
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
AU3912493A (en) A pharmaceutical composition containing a defined lipid system
BR9803300A (pt) Formulação farmacêutica.
DE69940674D1 (de) Orale verabreichung von adenosin analogen
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
CA2224528A1 (fr) Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations
GB2332147A (en) Therapeutically active compositions
NZ505919A (en) Nasal solutions
IS2789B (is) Lyfjablöndur sem innihalda mónóamínoxídasa B hemla
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
PT975348E (pt) Composicoes de tibolona estabilizadas
NO20005332L (no) 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding
DE69722594D1 (de) Pulverförmiges arzneimittel enthaltend interzelluläres adhäsionsmolekül
NO20012351L (no) Farmasoytisk sammensetning for modifisert frigjoring av insulinsensibiliserende middel
ES2176792T3 (es) Tabletas que contienen una resina de intercambio ionico.
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
ATE203903T1 (de) Delta-aminolävulinsäure enthaltendes arzneimittel
GR1002731B (el) Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0885010

Country of ref document: EP

REN Ceased due to non-payment of the annual fee